References
- [ATS] American Thoracic Society1995Standardization of spirometry: 1994 updateAm J Respir Crit Care Med1521107367663792
- BretzFSchmidliHKonigF2006Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general conceptsBiom J486233416972714
- BrusascoVHodderRMiravitllesM2003Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax5839940412728159
- CasaburiRMahlerDAJonesPW2002A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J192172411866001
- DalbyRSpallekMVoshaarT2004A review of the development of Respimat® Soft MistTM InhalerInt J Pharm2831915363496
- [GOLD] Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Executive summaryBethesda, MDNational Institutes of Health Updated 2006. URL: http://www.ersnet.org/lrPresentations/copd/files/main/contenu/pages/full_text.pdf (last accessed 11 June 2007)
- HochrainerDHolzHKreherC2005Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalersJ Aerosol Med182738216181002
- KilfeatherSAPonitzHHBeckE2004Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPDRespir Med983879715139567
- KoumisTSamuelS2005Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary diseaseClin Ther273779215922812
- MaesenFPVSmeetsJJSledsensTJH1995Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD)Eur Respir J81506138575576
- MaltaisFHamiltonAMarciniukD2005Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest12811687816162703
- NewmanSP1999Use of gamma scintigraphy to evaluate the performance of new inhalersJ Aerosol Med12Suppl 1S253110623338
- NewmanSPBrownJSteedKP1998Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicationsChest113957639554631
- NewmanSPSteedKPReaderSJ1996Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizerJ Pharm Sci8596048877887
- NiewoehnerDERiceKCoteC2000Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med14331726
- O’DonnellDEFlugeTGerkenF2004Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J238324015218994
- PitcairnGRReaderSPaviaD2005Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbohaler dry powder inhalerJ Aerosol Med182647216181001
- QuanjerPHTammelingGJCotesJE1993Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyEur Respir J Suppl165408499054
- SaberiFO’DonnellDE2005The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPDTreat Respir Med42758116086600
- SchuermannWSchmidtmannSMoroniP2005Respimat Soft Mist Inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfactionTreat Respir Med4536115725050
- VinckenWvan NoordJAGreefhorstAP2002Improved health outcomes in patients with COPD during 1-year treatment with tiotropiumEur Respir J192091611871363
- ZierenbergB1999Optimizing the in vitro performance of RespimatJ Aerosol Med12Suppl 1S192410623337